{"gene":"ZNF410","run_date":"2026-06-11T09:02:07","timeline":{"discoveries":[{"year":2020,"finding":"ZNF410 (a pentadactyl zinc-finger transcription factor) directly activates only a single gene in human erythroid cells — CHD4, a NuRD complex component — by binding to two highly evolutionarily conserved clusters of ZNF410 binding sites near the CHD4 gene that have no counterparts elsewhere in the genome. Loss of ZNF410 diminishes CHD4 protein levels and derepresses fetal hemoglobin (γ-globin) genes. In vitro DNA binding assays and crystallographic studies established the ZNF410–DNA binding mode.","method":"CRISPR-Cas9 genetic screen, in vitro DNA binding assays, X-ray crystallography, xenotransplantation loss-of-function","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — crystal structure, in vitro DNA binding, genetic screen, and loss-of-function phenotype in multiple erythroid systems; replicated in a concurrent independent study (PMID:33859416)","pmids":["33301730"],"is_preprint":false},{"year":2021,"finding":"ZNF410 chromatin occupancy is concentrated solely at the CHD4 locus (two regulatory elements with 27 combined ZNF410 binding motifs), and these elements completely account for the effect of ZNF410 on fetal globin repression. Knockout of ZNF410 or its mouse homolog Zfp410 reduces CHD4 protein levels by ~60%, sufficient to substantially de-repress fetal hemoglobin, without detectable cellular or organismal toxicity.","method":"TF CRISPR screen, ChIP-seq, ZNF410/Zfp410 knockout, flow cytometry for HbF, xenotransplantation","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal replication of the PMID:33301730 findings by an independent lab using orthogonal methods (ChIP-seq, CRISPR KO, mouse homolog KO, quantitative HbF measurement)","pmids":["33859416"],"is_preprint":false},{"year":2002,"finding":"APA-1/ZNF410 protein expression increases in senescent human fibroblasts and is modified by the ubiquitin-like protein SUMO-1, which increases APA-1 half-life (possibly by blocking ubiquitin-mediated degradation). Overexpression of APA-1 induces transcription of extracellular matrix-remodeling genes MMP1 and PAI2, and APA-1 can bind to and transactivate the MMP1 promoter, identifying it as a transcriptional activator of matrix-remodeling genes in fibroblast senescence.","method":"Overexpression, reporter/transactivation assays, DNA binding (promoter binding assay), SUMO-1 modification assay, protein half-life measurement","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — direct DNA binding and transactivation assays plus SUMO modification demonstrated in a single lab with multiple orthogonal methods, but not independently replicated","pmids":["12370286"],"is_preprint":false},{"year":2023,"finding":"Full-length ZNF410 has reduced DNA-binding affinity compared to its isolated zinc-finger (ZF) array, both in vitro and in cells. Small-angle X-ray scattering (SAXS) and AlphaFold modelling reveal that an N-terminal hairpin loop rich in acidic and Ser/Thr residues occupies the ZF DNA-binding interface in the absence of DNA, acting as a DNA-mimicking autoinhibitory element; displacement of this loop is required for DNA binding. ZNF410 is monomeric in solution and binds DNA with 1:1 stoichiometry.","method":"Small-angle X-ray scattering (SAXS), AlphaFold structural prediction with biophysical validation, in vitro DNA binding affinity assays, bioinformatics","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 1–3 / Moderate — SAXS structural data combined with in vitro binding assays and AlphaFold modelling in a single lab; mechanistic model (DNA-mimicry autoinhibition) is experimentally supported but not yet validated by mutagenesis","pmids":["36660822"],"is_preprint":false},{"year":2022,"finding":"Dual lentiviral knockdown of both BCL11A and ZNF410 (using a double shmiR vector) in human HSC-derived erythroid cells reduces both proteins by ~70% and yields a consistent additional ~10% increase in HbF compared to targeting BCL11A alone, demonstrating that ZNF410 represses fetal hemoglobin through a pathway partially independent of BCL11A.","method":"Lentiviral shmiR knockdown, flow cytometry for HbF, in vitro sickling assay, xenotransplantation in Berkeley SCD mice","journal":"Molecular therapy","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean dual KD with quantitative HbF readout and mouse model, single lab, multiple orthogonal readouts","pmids":["35526095"],"is_preprint":false},{"year":2025,"finding":"ZNF410 controls chromatin accessibility and enhancer activity at the CHD4 locus by binding cooperatively to homotypic clustered transcription factor binding sites (HCTs). Three ZNF410 motifs at the 3′ end of the distal CHD4 enhancer act as 'switch motifs' controlling chromatin accessibility. Mechanistically, the SWI/SNF complex is selectively required to mediate cooperative ZNF410 binding for CHD4 expression.","method":"ATAC-seq, ChIP-seq, motif deletion/mutagenesis of ZNF410 binding sites, SWI/SNF complex perturbation, reporter assays","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple chromatin assays and functional motif deletions in a single lab; SWI/SNF dependency established by perturbation experiments","pmids":["40158221"],"is_preprint":false}],"current_model":"ZNF410 is a highly conserved pentadactyl zinc-finger transcription factor that, in erythroid cells, functions as a remarkably selective activator of a single target gene, CHD4 (a NuRD complex component), by binding cooperatively to unique homotypic clusters of binding sites at the CHD4 locus; this activity requires the SWI/SNF complex for chromatin remodeling, is autoinhibited by an N-terminal hairpin loop that mimics DNA to occlude the zinc-finger DNA-binding surface, and is regulated by SUMO-1 modification; loss of ZNF410 reduces CHD4 levels ~60%, de-repressing fetal hemoglobin genes (γ-globin) by dismantling CHD4/NuRD-mediated silencing, and in non-erythroid (fibroblast) contexts ZNF410/APA-1 activates extracellular matrix remodeling genes (MMP1, PAI2) during cellular senescence."},"narrative":{"mechanistic_narrative":"ZNF410 is a highly conserved pentadactyl zinc-finger transcription factor that acts as a remarkably selective transcriptional activator, with its erythroid chromatin occupancy concentrated essentially at a single locus, CHD4 [PMID:33301730, PMID:33859416]. It binds two evolutionarily conserved regulatory elements bearing homotypic clusters of ZNF410 motifs that have no counterparts elsewhere in the genome, and these elements fully account for its downstream effects [PMID:33301730, PMID:33859416]. Cooperative binding to these clustered sites controls chromatin accessibility and enhancer activity at the CHD4 locus, with a subset of 3' enhancer motifs acting as accessibility 'switch motifs' and the SWI/SNF complex selectively required to support cooperative ZNF410 occupancy [PMID:40158221]. Because CHD4 is a NuRD component, loss of ZNF410 lowers CHD4 protein by ~60% and de-represses the fetal hemoglobin (γ-globin) genes, an effect that operates partially independently of BCL11A [PMID:33859416, PMID:35526095]. DNA binding by full-length ZNF410 is autoinhibited: an N-terminal hairpin loop rich in acidic and Ser/Thr residues mimics DNA and occupies the zinc-finger interface in the absence of substrate, and must be displaced for engagement; the protein is monomeric and binds DNA 1:1 [PMID:36660822]. In senescent fibroblasts, the same protein (APA-1) is stabilized by SUMO-1 modification and activates extracellular matrix-remodeling genes including MMP1 and PAI2, binding and transactivating the MMP1 promoter [PMID:12370286].","teleology":[{"year":2002,"claim":"Established ZNF410/APA-1 as a bona fide transcriptional activator and identified its first regulatory layer, showing it binds and transactivates a target promoter and is post-translationally stabilized by SUMO-1.","evidence":"Overexpression, promoter binding and transactivation assays, SUMO-1 modification and half-life measurement in senescent human fibroblasts","pmids":["12370286"],"confidence":"Medium","gaps":["Genome-wide target specificity not assessed","SUMO acceptor site not mapped","Not independently replicated"]},{"year":2020,"claim":"Resolved why ZNF410 matters in erythroid cells by showing it directly activates a single gene, CHD4, through unique conserved binding-site clusters, linking it to fetal hemoglobin silencing via NuRD.","evidence":"CRISPR-Cas9 screen, in vitro DNA binding, X-ray crystallography, and xenotransplantation loss-of-function in human erythroid systems","pmids":["33301730"],"confidence":"High","gaps":["Mechanism of single-gene selectivity beyond motif clustering unresolved","Did not address chromatin-remodeling cofactors"]},{"year":2021,"claim":"Independently confirmed the CHD4-restricted occupancy model and quantified the effect, showing ~60% CHD4 reduction is sufficient to de-repress fetal hemoglobin without toxicity.","evidence":"ChIP-seq, ZNF410 and mouse Zfp410 knockout, quantitative HbF flow cytometry, xenotransplantation","pmids":["33859416"],"confidence":"High","gaps":["Does not explain how partial CHD4 loss yields disproportionate de-repression","Therapeutic window in patient cells not defined"]},{"year":2022,"claim":"Positioned ZNF410 in the HbF regulatory hierarchy by showing it represses fetal hemoglobin through a pathway partially independent of BCL11A, supporting combinatorial targeting.","evidence":"Dual lentiviral shmiR knockdown of BCL11A and ZNF410, HbF flow cytometry, sickling assay, and Berkeley SCD mouse xenotransplantation","pmids":["35526095"],"confidence":"Medium","gaps":["Molecular point of convergence/divergence with BCL11A unmapped","Additive ~10% effect is modest"]},{"year":2023,"claim":"Explained how full-length ZNF410 controls its own DNA binding, identifying an N-terminal DNA-mimicking hairpin loop that autoinhibits the zinc-finger interface until displaced.","evidence":"SAXS, AlphaFold modeling with biophysical validation, and in vitro DNA-binding affinity assays","pmids":["36660822"],"confidence":"Medium","gaps":["Autoinhibition model not validated by mutagenesis","Physiological trigger for loop displacement unknown"]},{"year":2025,"claim":"Defined the chromatin mechanism of activation, showing cooperative binding to homotypic clustered sites and a selective SWI/SNF requirement set CHD4 enhancer accessibility.","evidence":"ATAC-seq, ChIP-seq, motif deletion/mutagenesis, SWI/SNF perturbation, and reporter assays at the CHD4 locus","pmids":["40158221"],"confidence":"Medium","gaps":["Direct physical ZNF410-SWI/SNF interaction not demonstrated","Single lab, not independently replicated"]},{"year":null,"claim":"How ZNF410 reconciles its erythroid single-gene selectivity with its broader activator role in fibroblast senescence remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["Cell-type determinants of target selectivity unknown","Whether SUMO regulation and autoinhibition operate at the CHD4 locus untested","No unified model linking erythroid and senescence functions"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,2,5]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,2,3]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,1]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,5]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[5]}],"complexes":[],"partners":["CHD4","SWI/SNF"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q86VK4","full_name":"Zinc finger protein 410","aliases":["Another partner for ARF 1"],"length_aa":478,"mass_kda":52.1,"function":"Transcription factor that binds to the sequence motif 5'-CATCCCATAATA-3', and is specifically required to silence expression of fetal hemoglobin in adult erythroid cells (PubMed:33301730, PubMed:33859416). Prevents expression of fetal hemoglobin genes HBG1 and HBG2 through CHD4: acts as a direct transcriptional activator of CHD4, a central component of the NuRD complex that represses transcription of fetal hemoglobin genes HBG1 and HBG2 in erythroid cells (PubMed:33301730, PubMed:33859416). May also activate transcription of matrix-remodeling genes such as MMP1 during fibroblast senescence (PubMed:12370286). May activate transcription of the gap junction gene GJC1, perhaps in response to increasing glucose (PubMed:30078215). However, recent studies suggest that ZNF410 is dedicated to regulate expression of a single gene: CHD4 (PubMed:33301730, PubMed:33859416)","subcellular_location":"Nucleus; Chromosome","url":"https://www.uniprot.org/uniprotkb/Q86VK4/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ZNF410","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/ZNF410","total_profiled":1310},"omim":[{"mim_id":"619427","title":"ZINC FINGER PROTEIN 410; ZNF410","url":"https://www.omim.org/entry/619427"},{"mim_id":"603277","title":"CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 4; CHD4","url":"https://www.omim.org/entry/603277"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/ZNF410"},"hgnc":{"alias_symbol":["APA1","APA-1"],"prev_symbol":[]},"alphafold":{"accession":"Q86VK4","domains":[{"cath_id":"3.30.160.60","chopping":"217-274","consensus_level":"medium","plddt":85.3276,"start":217,"end":274},{"cath_id":"2.20.150","chopping":"74-98_117-143","consensus_level":"medium","plddt":33.0158,"start":74,"end":143}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q86VK4","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q86VK4-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q86VK4-F1-predicted_aligned_error_v6.png","plddt_mean":48.34},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ZNF410","jax_strain_url":"https://www.jax.org/strain/search?query=ZNF410"},"sequence":{"accession":"Q86VK4","fasta_url":"https://rest.uniprot.org/uniprotkb/Q86VK4.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q86VK4/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q86VK4"}},"corpus_meta":[{"pmid":"33301730","id":"PMC_33301730","title":"ZNF410 Uniquely Activates the NuRD Component CHD4 to Silence Fetal Hemoglobin Expression.","date":"2020","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/33301730","citation_count":75,"is_preprint":false},{"pmid":"33859416","id":"PMC_33859416","title":"ZNF410 represses fetal globin by singular control of CHD4.","date":"2021","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/33859416","citation_count":62,"is_preprint":false},{"pmid":"12370286","id":"PMC_12370286","title":"Induction of extracellular matrix-remodeling genes by the senescence-associated protein APA-1.","date":"2002","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12370286","citation_count":42,"is_preprint":false},{"pmid":"2556364","id":"PMC_2556364","title":"Isolation, characterization, and inactivation of the APA1 gene encoding yeast diadenosine 5',5'''-P1,P4-tetraphosphate phosphorylase.","date":"1989","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/2556364","citation_count":34,"is_preprint":false},{"pmid":"29072133","id":"PMC_29072133","title":"Association between Vitamin D receptor (Cdx2, Fok1, Bsm1, Apa1, Bgl1, Taq1, and Poly (A)) gene polymorphism and breast cancer: A systematic review and meta-analysis.","date":"2017","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29072133","citation_count":32,"is_preprint":false},{"pmid":"25818350","id":"PMC_25818350","title":"The Adh adhesin domain is required for trimeric autotransporter Apa1-mediated Actinobacillus pleuropneumoniae adhesion, autoaggregation, biofilm formation and pathogenicity.","date":"2015","source":"Veterinary microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/25818350","citation_count":23,"is_preprint":false},{"pmid":"35526095","id":"PMC_35526095","title":"Development of a double shmiR lentivirus effectively targeting both BCL11A and ZNF410 for enhanced induction of fetal hemoglobin to treat β-hemoglobinopathies.","date":"2022","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/35526095","citation_count":22,"is_preprint":false},{"pmid":"23418495","id":"PMC_23418495","title":"1,25-dihydroxyvitamin D and the vitamin D receptor gene polymorphism Apa1 influence bone mineral density in primary hyperparathyroidism.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23418495","citation_count":19,"is_preprint":false},{"pmid":"27553621","id":"PMC_27553621","title":"Role of vitamin D receptor gene Cdx2 and Apa1 polymorphisms in prostate cancer susceptibility: a meta-analysis.","date":"2016","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/27553621","citation_count":14,"is_preprint":false},{"pmid":"29559350","id":"PMC_29559350","title":"Association of vitamin D receptor gene polymorphism (TaqI and Apa1) with bone mineral density in North Indian postmenopausal women.","date":"2018","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/29559350","citation_count":12,"is_preprint":false},{"pmid":"30155592","id":"PMC_30155592","title":"Vitamin D receptor gene polymorphisms (Apa1 and Taq1) in temporomandibular joint internal derangement/osteoarthritis in a group of Turkish patients.","date":"2018","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/30155592","citation_count":11,"is_preprint":false},{"pmid":"27958635","id":"PMC_27958635","title":"Influence of Apa1 (rs7975232), Taq1 (rs731236) and Bsm1 (rs154410) polymorphisms of vitamin D receptor on preterm birth risk in the Polish population.","date":"2016","source":"Ginekologia polska","url":"https://pubmed.ncbi.nlm.nih.gov/27958635","citation_count":11,"is_preprint":false},{"pmid":"31682785","id":"PMC_31682785","title":"Apa1 (rs7975232) SNP in the vitamin D receptor is linked to hepatocellular carcinoma in hepatitis C virus cirrhosis.","date":"2019","source":"British journal of biomedical science","url":"https://pubmed.ncbi.nlm.nih.gov/31682785","citation_count":11,"is_preprint":false},{"pmid":"16511027","id":"PMC_16511027","title":"Crystallization and preliminary X-ray crystallographic studies of a psychrophilic subtilisin-like protease Apa1 from Antarctic Pseudoalteromonas sp. strain AS-11.","date":"2005","source":"Acta crystallographica. Section F, Structural biology and crystallization communications","url":"https://pubmed.ncbi.nlm.nih.gov/16511027","citation_count":11,"is_preprint":false},{"pmid":"36660822","id":"PMC_36660822","title":"Allosteric autoregulation of DNA binding via a DNA-mimicking protein domain: a biophysical study of ZNF410-DNA interaction using small angle X-ray scattering.","date":"2023","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/36660822","citation_count":10,"is_preprint":false},{"pmid":"32311846","id":"PMC_32311846","title":"Analysis of 25-hydroxy cholecalciferol, immunoglobulin E, and vitamin D receptor single nucleotide polymorphisms (Apa1, Taq1, and Bsm1), among sample of Egyptian children with bronchial asthma: A case-control study.","date":"2020","source":"Pediatric pulmonology","url":"https://pubmed.ncbi.nlm.nih.gov/32311846","citation_count":10,"is_preprint":false},{"pmid":"38223006","id":"PMC_38223006","title":"An Updated Trial Sequential Meta-analysis of Vitamin D Receptor Gene Polymorphism (Fok1, Bsm1, Taq1 and Apa1) and Risk to Tuberculosis.","date":"2022","source":"Indian journal of clinical biochemistry : IJCB","url":"https://pubmed.ncbi.nlm.nih.gov/38223006","citation_count":7,"is_preprint":false},{"pmid":"27686292","id":"PMC_27686292","title":"Serum vitamin D levels and gene polymorphisms (Fok1 and Apa1) in children with type I diabetes and healthy controls.","date":"2016","source":"JPMA. The Journal of the Pakistan Medical Association","url":"https://pubmed.ncbi.nlm.nih.gov/27686292","citation_count":6,"is_preprint":false},{"pmid":"26290023","id":"PMC_26290023","title":"[Apa1 VDR polymorphism and osteoporosis risk in postmenopausal Mexican women].","date":"2015","source":"Gaceta medica de Mexico","url":"https://pubmed.ncbi.nlm.nih.gov/26290023","citation_count":6,"is_preprint":false},{"pmid":"33859418","id":"PMC_33859418","title":"Targeting ZNF410 as a potential β-hemoglobinopathy therapy.","date":"2021","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/33859418","citation_count":2,"is_preprint":false},{"pmid":"40158221","id":"PMC_40158221","title":"SWI/SNF complex-mediated ZNF410 cooperative binding maintains chromatin accessibility and enhancer activity.","date":"2025","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/40158221","citation_count":1,"is_preprint":false},{"pmid":"35638543","id":"PMC_35638543","title":"Genetic Association of VDR gene Apa1 and Taq1 Variants with Scleroderma in an Iranian Northeast Population.","date":"2023","source":"Current rheumatology reviews","url":"https://pubmed.ncbi.nlm.nih.gov/35638543","citation_count":1,"is_preprint":false},{"pmid":"38440355","id":"PMC_38440355","title":"The Relationship between VDR Gene Polymorphisms Bsm1 and Apa1 with Breast Cancer Risk.","date":"2024","source":"Global medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/38440355","citation_count":0,"is_preprint":false},{"pmid":"40390930","id":"PMC_40390930","title":"FOK1 and APA1 Gene Polymorphism Among Polycystic Ovary Syndrome: A Prospective Cohort Study.","date":"2024","source":"Journal of obstetrics and gynaecology of India","url":"https://pubmed.ncbi.nlm.nih.gov/40390930","citation_count":0,"is_preprint":false},{"pmid":"39062692","id":"PMC_39062692","title":"Exploring the Influence of Fok1/Apa1 Polymorphic Variants on Adolescent Mental Health and Response to Vitamin D Supplementation in Embryonic Hippocampal Cell Lines.","date":"2024","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/39062692","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":14668,"output_tokens":1989,"usd":0.03692,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":8933,"output_tokens":2415,"usd":0.05252,"stage2_stop_reason":"end_turn"},"total_usd":0.08944,"stage1_batch_id":"msgbatch_01UT1AahFPCAyn2uVweS7A9z","stage2_batch_id":"msgbatch_01HuKWtKNT4Pqj1bc8eEP5RV","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2020,\n      \"finding\": \"ZNF410 (a pentadactyl zinc-finger transcription factor) directly activates only a single gene in human erythroid cells — CHD4, a NuRD complex component — by binding to two highly evolutionarily conserved clusters of ZNF410 binding sites near the CHD4 gene that have no counterparts elsewhere in the genome. Loss of ZNF410 diminishes CHD4 protein levels and derepresses fetal hemoglobin (γ-globin) genes. In vitro DNA binding assays and crystallographic studies established the ZNF410–DNA binding mode.\",\n      \"method\": \"CRISPR-Cas9 genetic screen, in vitro DNA binding assays, X-ray crystallography, xenotransplantation loss-of-function\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — crystal structure, in vitro DNA binding, genetic screen, and loss-of-function phenotype in multiple erythroid systems; replicated in a concurrent independent study (PMID:33859416)\",\n      \"pmids\": [\"33301730\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"ZNF410 chromatin occupancy is concentrated solely at the CHD4 locus (two regulatory elements with 27 combined ZNF410 binding motifs), and these elements completely account for the effect of ZNF410 on fetal globin repression. Knockout of ZNF410 or its mouse homolog Zfp410 reduces CHD4 protein levels by ~60%, sufficient to substantially de-repress fetal hemoglobin, without detectable cellular or organismal toxicity.\",\n      \"method\": \"TF CRISPR screen, ChIP-seq, ZNF410/Zfp410 knockout, flow cytometry for HbF, xenotransplantation\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal replication of the PMID:33301730 findings by an independent lab using orthogonal methods (ChIP-seq, CRISPR KO, mouse homolog KO, quantitative HbF measurement)\",\n      \"pmids\": [\"33859416\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"APA-1/ZNF410 protein expression increases in senescent human fibroblasts and is modified by the ubiquitin-like protein SUMO-1, which increases APA-1 half-life (possibly by blocking ubiquitin-mediated degradation). Overexpression of APA-1 induces transcription of extracellular matrix-remodeling genes MMP1 and PAI2, and APA-1 can bind to and transactivate the MMP1 promoter, identifying it as a transcriptional activator of matrix-remodeling genes in fibroblast senescence.\",\n      \"method\": \"Overexpression, reporter/transactivation assays, DNA binding (promoter binding assay), SUMO-1 modification assay, protein half-life measurement\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — direct DNA binding and transactivation assays plus SUMO modification demonstrated in a single lab with multiple orthogonal methods, but not independently replicated\",\n      \"pmids\": [\"12370286\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Full-length ZNF410 has reduced DNA-binding affinity compared to its isolated zinc-finger (ZF) array, both in vitro and in cells. Small-angle X-ray scattering (SAXS) and AlphaFold modelling reveal that an N-terminal hairpin loop rich in acidic and Ser/Thr residues occupies the ZF DNA-binding interface in the absence of DNA, acting as a DNA-mimicking autoinhibitory element; displacement of this loop is required for DNA binding. ZNF410 is monomeric in solution and binds DNA with 1:1 stoichiometry.\",\n      \"method\": \"Small-angle X-ray scattering (SAXS), AlphaFold structural prediction with biophysical validation, in vitro DNA binding affinity assays, bioinformatics\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–3 / Moderate — SAXS structural data combined with in vitro binding assays and AlphaFold modelling in a single lab; mechanistic model (DNA-mimicry autoinhibition) is experimentally supported but not yet validated by mutagenesis\",\n      \"pmids\": [\"36660822\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Dual lentiviral knockdown of both BCL11A and ZNF410 (using a double shmiR vector) in human HSC-derived erythroid cells reduces both proteins by ~70% and yields a consistent additional ~10% increase in HbF compared to targeting BCL11A alone, demonstrating that ZNF410 represses fetal hemoglobin through a pathway partially independent of BCL11A.\",\n      \"method\": \"Lentiviral shmiR knockdown, flow cytometry for HbF, in vitro sickling assay, xenotransplantation in Berkeley SCD mice\",\n      \"journal\": \"Molecular therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean dual KD with quantitative HbF readout and mouse model, single lab, multiple orthogonal readouts\",\n      \"pmids\": [\"35526095\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"ZNF410 controls chromatin accessibility and enhancer activity at the CHD4 locus by binding cooperatively to homotypic clustered transcription factor binding sites (HCTs). Three ZNF410 motifs at the 3′ end of the distal CHD4 enhancer act as 'switch motifs' controlling chromatin accessibility. Mechanistically, the SWI/SNF complex is selectively required to mediate cooperative ZNF410 binding for CHD4 expression.\",\n      \"method\": \"ATAC-seq, ChIP-seq, motif deletion/mutagenesis of ZNF410 binding sites, SWI/SNF complex perturbation, reporter assays\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple chromatin assays and functional motif deletions in a single lab; SWI/SNF dependency established by perturbation experiments\",\n      \"pmids\": [\"40158221\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ZNF410 is a highly conserved pentadactyl zinc-finger transcription factor that, in erythroid cells, functions as a remarkably selective activator of a single target gene, CHD4 (a NuRD complex component), by binding cooperatively to unique homotypic clusters of binding sites at the CHD4 locus; this activity requires the SWI/SNF complex for chromatin remodeling, is autoinhibited by an N-terminal hairpin loop that mimics DNA to occlude the zinc-finger DNA-binding surface, and is regulated by SUMO-1 modification; loss of ZNF410 reduces CHD4 levels ~60%, de-repressing fetal hemoglobin genes (γ-globin) by dismantling CHD4/NuRD-mediated silencing, and in non-erythroid (fibroblast) contexts ZNF410/APA-1 activates extracellular matrix remodeling genes (MMP1, PAI2) during cellular senescence.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"ZNF410 is a highly conserved pentadactyl zinc-finger transcription factor that acts as a remarkably selective transcriptional activator, with its erythroid chromatin occupancy concentrated essentially at a single locus, CHD4 [#0, #1]. It binds two evolutionarily conserved regulatory elements bearing homotypic clusters of ZNF410 motifs that have no counterparts elsewhere in the genome, and these elements fully account for its downstream effects [#0, #1]. Cooperative binding to these clustered sites controls chromatin accessibility and enhancer activity at the CHD4 locus, with a subset of 3' enhancer motifs acting as accessibility 'switch motifs' and the SWI/SNF complex selectively required to support cooperative ZNF410 occupancy [#5]. Because CHD4 is a NuRD component, loss of ZNF410 lowers CHD4 protein by ~60% and de-represses the fetal hemoglobin (γ-globin) genes, an effect that operates partially independently of BCL11A [#1, #4]. DNA binding by full-length ZNF410 is autoinhibited: an N-terminal hairpin loop rich in acidic and Ser/Thr residues mimics DNA and occupies the zinc-finger interface in the absence of substrate, and must be displaced for engagement; the protein is monomeric and binds DNA 1:1 [#3]. In senescent fibroblasts, the same protein (APA-1) is stabilized by SUMO-1 modification and activates extracellular matrix-remodeling genes including MMP1 and PAI2, binding and transactivating the MMP1 promoter [#2].\",\n  \"teleology\": [\n    {\n      \"year\": 2002,\n      \"claim\": \"Established ZNF410/APA-1 as a bona fide transcriptional activator and identified its first regulatory layer, showing it binds and transactivates a target promoter and is post-translationally stabilized by SUMO-1.\",\n      \"evidence\": \"Overexpression, promoter binding and transactivation assays, SUMO-1 modification and half-life measurement in senescent human fibroblasts\",\n      \"pmids\": [\"12370286\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Genome-wide target specificity not assessed\", \"SUMO acceptor site not mapped\", \"Not independently replicated\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Resolved why ZNF410 matters in erythroid cells by showing it directly activates a single gene, CHD4, through unique conserved binding-site clusters, linking it to fetal hemoglobin silencing via NuRD.\",\n      \"evidence\": \"CRISPR-Cas9 screen, in vitro DNA binding, X-ray crystallography, and xenotransplantation loss-of-function in human erythroid systems\",\n      \"pmids\": [\"33301730\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of single-gene selectivity beyond motif clustering unresolved\", \"Did not address chromatin-remodeling cofactors\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Independently confirmed the CHD4-restricted occupancy model and quantified the effect, showing ~60% CHD4 reduction is sufficient to de-repress fetal hemoglobin without toxicity.\",\n      \"evidence\": \"ChIP-seq, ZNF410 and mouse Zfp410 knockout, quantitative HbF flow cytometry, xenotransplantation\",\n      \"pmids\": [\"33859416\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Does not explain how partial CHD4 loss yields disproportionate de-repression\", \"Therapeutic window in patient cells not defined\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Positioned ZNF410 in the HbF regulatory hierarchy by showing it represses fetal hemoglobin through a pathway partially independent of BCL11A, supporting combinatorial targeting.\",\n      \"evidence\": \"Dual lentiviral shmiR knockdown of BCL11A and ZNF410, HbF flow cytometry, sickling assay, and Berkeley SCD mouse xenotransplantation\",\n      \"pmids\": [\"35526095\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular point of convergence/divergence with BCL11A unmapped\", \"Additive ~10% effect is modest\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Explained how full-length ZNF410 controls its own DNA binding, identifying an N-terminal DNA-mimicking hairpin loop that autoinhibits the zinc-finger interface until displaced.\",\n      \"evidence\": \"SAXS, AlphaFold modeling with biophysical validation, and in vitro DNA-binding affinity assays\",\n      \"pmids\": [\"36660822\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Autoinhibition model not validated by mutagenesis\", \"Physiological trigger for loop displacement unknown\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Defined the chromatin mechanism of activation, showing cooperative binding to homotypic clustered sites and a selective SWI/SNF requirement set CHD4 enhancer accessibility.\",\n      \"evidence\": \"ATAC-seq, ChIP-seq, motif deletion/mutagenesis, SWI/SNF perturbation, and reporter assays at the CHD4 locus\",\n      \"pmids\": [\"40158221\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct physical ZNF410-SWI/SNF interaction not demonstrated\", \"Single lab, not independently replicated\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How ZNF410 reconciles its erythroid single-gene selectivity with its broader activator role in fibroblast senescence remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Cell-type determinants of target selectivity unknown\", \"Whether SUMO regulation and autoinhibition operate at the CHD4 locus untested\", \"No unified model linking erythroid and senescence functions\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 2, 5]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 2, 3]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 5]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [5]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"CHD4\", \"SWI/SNF\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}